• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗帕金森病的进展期。

Treating the progressive stages of Parkinson's disease.

作者信息

Varon J, Jacobs M B

机构信息

Department of Medicine, Stanford University School of Medicine, California.

出版信息

Postgrad Med. 1991 Jul;90(1):63-6, 69-71. doi: 10.1080/00325481.1991.11700979.

DOI:10.1080/00325481.1991.11700979
PMID:1905807
Abstract

Parkinson's disease affects thousands of Americans, men and women equally and apparently with little regard to race. Its diagnosis depends largely on repeated clinical observations of representative signs, such as resting tremor, rigidity, bradykinesia, and gait disturbances. Patients progress through stages: Early disease involves only one limb or side and confers minimal disability, but advanced disease restricts patients to full care. Treatment is chosen on the basis of disease stage and patient response. Combination carbidopa-levodopa (Sinemet) is appropriate for any significant degree of disability, and other antiparkinsonian drugs and anticholinergic agents may be used as adjuncts. Electroconvulsive therapy, use of selegiline hydrochloride (Eldepryl), and surgery are still undergoing investigation but may hold promise.

摘要

帕金森病影响着成千上万的美国人,男性和女性受影响程度相同,且显然与种族关系不大。其诊断主要依赖于对典型症状的反复临床观察,如静止性震颤、僵硬、运动迟缓及步态障碍。患者会经历不同阶段:早期疾病仅累及一个肢体或一侧身体,导致的残疾程度最小,但晚期疾病会使患者需要完全护理。治疗方案根据疾病阶段和患者反应来选择。复方卡比多巴-左旋多巴(息宁)适用于任何显著程度的残疾情况,其他抗帕金森病药物和抗胆碱能药物可作为辅助用药。电休克疗法、盐酸司来吉兰(思吉宁)的使用以及手术仍在研究中,但可能具有前景。

相似文献

1
Treating the progressive stages of Parkinson's disease.治疗帕金森病的进展期。
Postgrad Med. 1991 Jul;90(1):63-6, 69-71. doi: 10.1080/00325481.1991.11700979.
2
Treatment of early Parkinson's disease: are complicated strategies justified?早期帕金森病的治疗:复杂策略是否合理?
Mayo Clin Proc. 1996 Jul;71(7):659-70. doi: 10.1016/S0025-6196(11)63004-8.
3
Pharmacotherapy: problems and practices.药物治疗:问题与实践
Clin Neuropharmacol. 1986;9 Suppl 1:S23-36.
4
The effect of deprenyl and levodopa on the progression of Parkinson's disease.司来吉兰和左旋多巴对帕金森病进展的影响。
Ann Neurol. 1995 Nov;38(5):771-7. doi: 10.1002/ana.410380512.
5
Treatment of Parkinson's disease.帕金森病的治疗。
Aust Fam Physician. 1995 Sep;24(9):1685-7, 1690-2.
6
Drugs for parkinsonism.治疗帕金森病的药物。
Med Lett Drugs Ther. 1986 Jun 20;28(716):62-4.
7
Drugs for parkinsonism.治疗帕金森病的药物。
Med Lett Drugs Ther. 1988 Dec 16;30(781):113-6.
8
Treatment of Parkinson's disease. From theory to practice.帕金森病的治疗。从理论到实践。
Postgrad Med. 1994 Apr;95(5):52-4, 57-8, 61-4 passim.
9
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.溴隐亭(帕罗西汀)与左旋多巴-卡比多巴(息宁)治疗“初发”帕金森病患者的比较。
Can J Neurol Sci. 1987 Nov;14(4):576-80.
10
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.甲磺酸培高利特作为息宁辅助药物治疗帕金森病的双盲对照研究。
Adv Neurol. 1987;45:555-60.

引用本文的文献

1
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.从 bench 到床边综述:横纹肌溶解症——临床医生概述
Crit Care. 2005 Apr;9(2):158-69. doi: 10.1186/cc2978. Epub 2004 Oct 20.